Trial
NCT02443545
Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias
Phase IVTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
ApoPharma
Collaborators
—
Condition
Iron Overload
Intervention
Deferiprone
Why stopped
Recommendation by DSMB, which felt that sufficient data had been obtained
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-10